Association between Isolated Hypercholesterolemia, Isolated Hypertriglyceridemia and Coronary Artery Disease in South Indian Type 2 Diabetic Patients

Indian Heart Journal

Volumn 52, Issue 4, 2000, Pages 400-406

  Rajmohan, L ^a   Deepa, R ^a   Mohan, Anjana ^a   Mohan, V ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; COMORBIDITY; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INDIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; COMORBIDITY; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INDIA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0034217825     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease: The Framingham Study. JAMA 1979; 241: 2035-2038
2. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed pre-diabetic individuals: Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 263: 2893-2898
3. Balarajan R. Ethnic difference in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. Br Med J 1991; 302: 560-564
4. Mckeigue PM, Miller GJ, Marmot MG. Coronary artery disease in South Asian overseas: A review. J Clin Epidemiol 1989; 41: 597-608
5. Enas EA, Garg A, Davidson MA, et al. Coronary heart disease and its risk factors in first generation immigrant Asian Indians to the United States of America. Indian Heart J 1996; 48: 343-354
6. Anand SS, Yusuf S, Vuksan V, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: The Study of Health Assessment and Risk in Ethnic Groups (SHARE). Lancet 2000; 356: 279-284
7. Reddy KS, Yusuf S. Emerging epidemic of CVD in the developing countries. Circulation 1997; 87: 596-601
8. Bhatnagar D, Anand IS, Durrington PN, et al. Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet 1995; 345: 405-409
9. Mckeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-386
10. Pinto RJ. Risk factors for coronary heart disease in Asian Indians: Clinical implications for prevention of coronary heart disease. Indian J Med Sci 1998; 52: 49-54
11. Jappensen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease: An 8-year follow-up in the Copenhagen Male study. Arterioscler Thromb Vasc Biol 1997; 17: 1114-1120
12. Hulley SB, Rosenman RH, Bawol RD, Brand RJ. Epidemiology as a guide to clinical decisions: The association between triglyceride and coronary heart disease. N Engl J Med 1980; 302: 1383-1389
13. Ginsberg HN. Is hypertriglyceridemia a risk factor for atherosclerotic cardiovascular disease? A simple question with a complicated answer. Ann Intern Med 1997; 126: 912-914
14. Avins AL, Neuhaus JM. Do triglycerides provide meaningful information about heart disease risk? Ann Intern Med 2000; 160: 1937-1944
15. Wild SH, Laws A, Fortmann SP, Varady AN, Byrne CD. Mortality from coronary heart disease and stroke for six ethnic groups in California, 1985 to 1990. Ann Epidemiol 1995; 5: 432-439
16. Graille V, Ferrieres J, Evans A, Amouyel P, Arveiler D, Luc G, Ducimetiere P. Associations between classical cardiovascular risk factors and coronary artery disease in two countries at contrasting risk for myocardial infarction: The PRIME study. Intern J Cardiol 2000; 74: 191-198
17. Mohan V, Ravikumar RK, Shanthirani CS, Deepa R. Intimal medical thickness of the carotid artery in South Indian diabetic and non-diabetic subjects - The Chennai Urban Population Study (CUPS). Diabetologia 2000; 43: 494-499
18. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, Part I: Diagnosis and classification of diabetes mellitus. Provisional report of WHO Consultation. Diab Med 1998; 15: 539-553
19. Trinder P. Determination of blood glucose using 4-amino phenazone as oxygen acceptor. J Clin Pathol 1969; 22: 246-250
20. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983; 29: 1075-1080
21. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Biochem 1984; 22: 165-174
22. Tallet F, Raichvarg D, Lefevre G, Canal J, Yonger J. Total automated method for determination of cholesterol concentration in high density lipoprotein by heparin-magnesium-albumin precipitation. Clin Chim Acta 1982; 123: 339-345
23. Bartels H, Bohmer M, Heierli C. Serum creatinine determination without protein precipitation. Clin Chim Acta 1972; 37: 193-197
24. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
25. Joint National Committee on Detection, Evaluation and treatment of high blood pressure: The fifth report of the Joint National Committee on Detection, Evaluation and treatment of high blood pressure (JNC-V). Arch Intern Med 1993; 153: 154-183
26. Lehto S, Ronnemaa T, Haffner SM, et al. Dyslipidemia and hyperglycaemia predict coronary heart disease events in middle aged patients with NIDDM. Diabetes 1997; 46: 1354-1359
27. Haffner SM. Coronary heart disease in patients with diabetes. N Engl J Med 2000; 342: 1040-1042
28. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from CAD in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234
29. West KM, Ahuja MM, Bennett PH, et al. The role of circulating glucose and triglyceride concentrations and their interactions with other risk factors and determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diab Care 1983; 6: 361-369
30. Fontbonne A, Eschwege E, Cambrene F, et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989; 32: 300-304
31. Turner RC, Millns H, Neil HAW, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus. United Kingdom Prospective Diabetes Study (UKPDS: 23). Br Med J 1998; 316: 823-828
32. Lipid Research Clinic Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results II. The relationship of reduction in incidence of coronary heart disease of cholesterol lowering. JAMA 1984; 251: 365-374
33. Grady D, Rubin SM, Pettiti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016-1037
34. Assmann G, Schulte H. Relation of high density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM Experience). Coronary Artery Disease in PROCAM 1992; pp 733-737
35. Huttunen JK, Manninen V, Mantari M, et al. The Helsinki Heart Study: Central findings and clinical implications. Ann Med 1991; 23: 155-159
36. Castelli WP. The triglyceride issue: A view from Framingham. Am Heart J 1986; 112: 432-440
37. The Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. The Scandinavian Simvastatin Sruvival Study. Lancet 1994; 344: 1383-1389
38. Pyorala K, Pedersen TR, Kjekshus J. For the Scandinavian Simvastatin Survival Study (4S) group. The effect of cholesterol lowering with simvastatin on coronary events in diabetic patients with coronary heart disease. Diabetes 1995; 44: 35A
39. Sacks FM, Pfeffer MA, Move LA, et al. For the CARE trial investigators: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-1009
40. American Diabetes Association. Management of dyslipidemia in adults with diabetes - Position statement: Clinical practice recommendations 1998. Diab Care 1998; 21: S36-S39
41. Kulkarni RK, Markovitz JH, Nanda NC, Segrest JP. Increased prevalence of smaller and denser LDL particles in Asian Indians. Atheroscler Thromb Vasc Biol 1999; 19: 2749-2755
42. Byrne CD. Triglyceride rich lipoprotein: Are links with atherosclerosis mediated by a procoagulant pro-inflammatory phenotype? Atherosclerosis 1999; 145: 1-15
43. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin and leucocyte count with coronary heart disease: Meta analysis of prospective studies. JAMA 1998; 279: 1477-1482